ZA744243B - Pharmaceutical tablet - Google Patents
Pharmaceutical tabletInfo
- Publication number
- ZA744243B ZA744243B ZA00744243A ZA744243A ZA744243B ZA 744243 B ZA744243 B ZA 744243B ZA 00744243 A ZA00744243 A ZA 00744243A ZA 744243 A ZA744243 A ZA 744243A ZA 744243 B ZA744243 B ZA 744243B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical tablet
- tablet
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3321473A GB1466857A (en) | 1973-07-12 | 1973-07-12 | Urea tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA744243B true ZA744243B (en) | 1975-06-25 |
Family
ID=10350041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00744243A ZA744243B (en) | 1973-07-12 | 1974-07-02 | Pharmaceutical tablet |
Country Status (12)
Country | Link |
---|---|
US (1) | US3996365A (sv) |
JP (1) | JPS5714650B2 (sv) |
BE (1) | BE817515A (sv) |
CA (1) | CA1039653A (sv) |
DE (1) | DE2433424A1 (sv) |
DK (1) | DK146843C (sv) |
FR (1) | FR2236485B1 (sv) |
GB (1) | GB1466857A (sv) |
IE (1) | IE39557B1 (sv) |
NL (1) | NL178563C (sv) |
SE (1) | SE392037B (sv) |
ZA (1) | ZA744243B (sv) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007002924A1 (de) | 2007-01-19 | 2008-07-24 | Bayer Healthcare Ag | ß-Lactam-haltige Formulierungen mit erhöhter Stabilität in wässriger Lösung |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679801A (en) * | 1970-05-19 | 1972-07-25 | Pfizer | Aryl esters of {60 -carboxyarylmethyl-penicillins |
-
1973
- 1973-07-12 GB GB3321473A patent/GB1466857A/en not_active Expired
-
1974
- 1974-06-26 IE IE1359/74A patent/IE39557B1/xx unknown
- 1974-07-02 ZA ZA00744243A patent/ZA744243B/xx unknown
- 1974-07-02 US US05/485,163 patent/US3996365A/en not_active Expired - Lifetime
- 1974-07-03 NL NLAANVRAGE7408986,A patent/NL178563C/xx not_active IP Right Cessation
- 1974-07-04 CA CA204,079A patent/CA1039653A/en not_active Expired
- 1974-07-10 SE SE7409100A patent/SE392037B/sv unknown
- 1974-07-10 BE BE146447A patent/BE817515A/xx not_active IP Right Cessation
- 1974-07-10 JP JP7967774A patent/JPS5714650B2/ja not_active Expired
- 1974-07-11 DE DE2433424A patent/DE2433424A1/de not_active Withdrawn
- 1974-07-11 DK DK374674A patent/DK146843C/da not_active IP Right Cessation
- 1974-07-11 FR FR7424115A patent/FR2236485B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK374674A (sv) | 1975-03-03 |
DE2433424A1 (de) | 1975-01-30 |
NL178563B (nl) | 1985-11-18 |
DK146843B (da) | 1984-01-23 |
SE7409100L (sv) | 1975-01-13 |
DK146843C (da) | 1984-07-16 |
NL7408986A (nl) | 1975-01-14 |
US3996365A (en) | 1976-12-07 |
JPS5714650B2 (sv) | 1982-03-25 |
NL178563C (nl) | 1986-04-16 |
AU7113574A (en) | 1976-01-15 |
IE39557B1 (en) | 1978-11-08 |
GB1466857A (en) | 1977-03-09 |
FR2236485A1 (sv) | 1975-02-07 |
JPS5031025A (sv) | 1975-03-27 |
SE392037B (sv) | 1977-03-14 |
BE817515A (fr) | 1975-01-10 |
CA1039653A (en) | 1978-10-03 |
IE39557L (en) | 1975-01-12 |
FR2236485B1 (sv) | 1978-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7259274A (en) | Medicaments | |
ZA731808B (en) | Pharmaceutical compositions | |
AU6592274A (en) | Capsules | |
HK41078A (en) | Pharmaceutical composition | |
IL44646A0 (en) | Novel pharmaceutical tablets | |
PH10938A (en) | Solid ophthalmic medicinal product | |
HK72578A (en) | Pharmaceutical compositions | |
AU7201374A (en) | Pharmaceutical compositions | |
ZA7461B (en) | Pharmaceutical formulation | |
AU6980774A (en) | Capsules | |
HK1378A (en) | Tablet formulation | |
ZA731012B (en) | Pharmaceutical compositions | |
AU7194974A (en) | Pharmaceutical product | |
ZA732439B (en) | Pharmaceutical composition | |
HK57578A (en) | Pharmaceutical compositions | |
CA940452A (en) | Pharmaceutical tablet | |
ZA744243B (en) | Pharmaceutical tablet | |
IL46223A0 (en) | Drug interaction system | |
AU6595174A (en) | Capsules | |
ZA728553B (en) | Tablets | |
ZA742528B (en) | Pharmaceutical tablets | |
AU7274074A (en) | Drug | |
ZA734331B (en) | Pharmaceutical compositions | |
AU480426B2 (en) | Pharmaceutical tablets | |
HK53780A (en) | Pharmaceutical preparations |